CALML3 antisense RNA 1 (CALML3-AS1), an oncogene, promoted the malignancy and stemness of small cell lung cancer (SCLC) cells by interacting with death domain-associated protein (DAXX) to enhance GLUT4-mediated aerobic glycolysis, thereby promoting SCLC progression.
[Toxicology and Applied Pharmacology]
